Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00394823 | VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients | PHASE3 | COMPLETED | 206 | — | — | Nov 1, 2005 | Jun 1, 2007 | May 18, 2017 | 2 | Germany, Switzerland |
| Name | Type | Description |
|---|---|---|
| Set of supportive tools/measures vs. standard care | BEHAVIORAL | - |
Inclusion Criteria: * Male or female patients \>= 18 years * Females must be either post-menopausal for one year, surgically sterile or using effective contraceptive methods (e.g. barrier method with spermicide, intra-uterine device, hormonal contraceptives). * Patients with mild essential hyperten...